[HTML][HTML] Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging

A Evans, RM Trimboli, A Athanasiou, C Balleyguier… - Insights into …, 2018 - Springer
This article summarises the information that should be provided to women and referring
physicians about breast ultrasound (US). After explaining the physical principles, technical …

[HTML][HTML] Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant …

A Rodríguez-Martínez, D de Miguel-Pérez… - Breast Cancer …, 2019 - Springer
Background Breast cancer patients under neoadjuvant chemotherapy includes a
heterogeneous group of patients who eventually develop distal disease, not detectable by …

Impact of 18F-labeled fluorodeoxyglucose positron emission tomography-computed tomography versus conventional staging in patients with locally advanced breast …

IS Dayes, U Metser, N Hodgson… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE Patients with locally advanced breast cancer (LABC) typically undergo staging
tests at presentation. If staging does not detect metastases, treatment consists of curative …

[HTML][HTML] Monitoring breast cancer response to neoadjuvant chemotherapy using ultrasound strain elastography

J Fernandes, L Sannachi, WT Tran, A Koven… - Translational …, 2019 - Elsevier
Strain elastography was used to monitor response to neoadjuvant chemotherapy (NAC) in
92 patients with biopsy-proven, locally advanced breast cancer. Strain elastography data …

[HTML][HTML] IL-8 secreted by tumor associated macrophages contribute to lapatinib resistance in HER2-positive locally advanced breast cancer via activation of Src/STAT3 …

S Ahmed, HT Mohamed, N El-Husseiny… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Locally advanced breast cancer (LABC) is an aggressive disease characterized by late
clinical presentation, large tumor size, treatment resistance and low survival rate. Expression …

Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients

AM Ibrahim, MM Said, AM Hilal, AM Medhat… - Tumor …, 2020 - journals.sagepub.com
This study aimed at investigating the expression of candidate microRNAs (miRs), at initial
diagnosis, during neoadjuvant chemotherapy, and after the tumor resection in locally …

Chitosan IR806 dye-based polyelectrolyte complex nanoparticles with mitoxantrone combination for effective chemo-photothermal therapy of metastatic triple-negative …

SB Alvi, PS Rajalakshmi, AB Jogdand, B Nazia… - International Journal of …, 2022 - Elsevier
Chemo-photothermal therapy is one of the emerging therapies for treating triple-negative
breast cancer. In this study, we have used ionotropic gelation method to fabricate chitosan …

Locally advanced breast cancer (LABC) and delayed care: a qualitative analysis of psychosocial factors

E Saita, C Acquati, S Molgora, D Vagnini… - Psychology, Health & …, 2023 - Taylor & Francis
The literature has extensively documented how delayed access to health care services in
the context of cancer can result from subjective characteristics, dysfunctional coping styles …

[HTML][HTML] Evaluation of psychological distress is essential for patients with locally advanced breast cancer prior to neoadjuvant chemotherapy: baseline findings from …

M Omari, L Amaadour, B Zarrouq, YA Al-Sheikh… - BMC Women's …, 2023 - Springer
Background patients with locally advanced breast cancer (LABC) are often treated by
neoadjuvant chemotherapy (NACT). This study aims to determine the prevalence of …

Imaging biomarkers for precision medicine in locally advanced breast cancer

WT Tran, C Childs, H Probst, G Farhat… - Journal of Medical …, 2018 - Elsevier
Abstract Guidelines from the American National Comprehensive Cancer Network
recommend neoadjuvant chemotherapy to patients with locally advanced breast cancer …